Plain-English translation of NCT07327489 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how to better predict which cancer patients will respond well to immunotherapy—a type of treatment that helps the immune system fight cancer. They're doing this by taking small tumor samples and testing how they react to immunotherapy in the lab, then comparing those results to how patients actually respond to treatment in real life.
Right now, doctors cannot reliably predict ahead of time which cancer patients will benefit from immunotherapy and which won't. This research aims to develop a better test using tumor samples that could help doctors choose the right treatment for each patient and avoid unnecessary side effects for those unlikely to benefit.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate a small piece of tumor tissue that is being removed as part of your regular cancer diagnosis or treatment plan. The researchers will test how your tumor responds to immunotherapy in the laboratory and combine that information with your medical and genetic data. Your involvement is mainly just allowing them to use the tissue sample that would otherwise be discarded, along with your clinical information.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States